FDA product code GGL: Control, White-Cell

GGL is the FDA product code for control, white-cell. It is a Class II device, regulated under 21 CFR 864.8625 and reviewed by the Hematology panel. FDA has cleared 8 510(k) submissions under GGL, from 4 different applicants. The average 510(k) review took 106 days (median 62).

Classification

FieldValue
Device nameControl, White-Cell
Device classClass II
Regulation21 CFR 864.8625
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k) exempt

Compare with all 510(k) review times · Search every GGL clearance

Top GGL applicants

ApplicantClearancesLatest
Streck Laboratories, Inc.41999-11-26
Streck22009-02-11
Coulter Corp.11989-09-13
Elite Diagnostic , Ltd.11989-04-10

Most recent GGL clearances

510(k)ApplicantDeviceDecision dateReview days
K083926StreckCD4 COUNT2009-02-1142
K051633StreckCD-CHEX PLUS BC2005-08-1657
K993126Streck Laboratories, Inc.CD-CHEX CD 341999-11-2667
K960894Streck Laboratories, Inc.CD-CHEX + RBC1996-05-2480
K931825Streck Laboratories, Inc.CD-CHEX CD4 LOW1994-06-06426

Recalls for GGL devices

openFDA lists no recalls for product code GGL.

Frequently asked questions

What is FDA product code GGL?

GGL is the FDA product code for control, white-cell. It is a Class II device, regulated under 21 CFR 864.8625 and reviewed by the Hematology panel.

What device class is GGL?

Class II, regulation 21 CFR 864.8625. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code GGL?

Across 8 cleared submissions the average was 106 days from receipt to decision (median 62).

Which companies have the most GGL clearances?

Streck Laboratories, Inc. (4); Streck (2); Coulter Corp. (1); Elite Diagnostic , Ltd. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times